Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from strong opioids to Transtec in cancer pain
2004-004624-13Phase 4Terminated
- Sponsor
- Barts Health NHS Trust
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of buprenorphine in cancer pain, sponsored by Barts Health NHS Trust. Primary endpoint: Pain intensity. Started Mar 2005; status: terminated.
02
Drugs
buprenorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2004-004624-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004624-13.